{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:07:24Z","timestamp":1790096844380,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012553","name":"chang gung memorial hospital","doi-asserted-by":"publisher","award":["CMRPG8H1301"],"award-info":[{"award-number":["CMRPG8H1301"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"chang gung memorial hospital","doi-asserted-by":"publisher","award":["CMRPG8J0881"],"award-info":[{"award-number":["CMRPG8J0881"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"chang gung memorial hospital","doi-asserted-by":"publisher","award":["CMRPG8J0882"],"award-info":[{"award-number":["CMRPG8J0882"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"chang gung memorial hospital","doi-asserted-by":"publisher","award":["CMRPG8J0661"],"award-info":[{"award-number":["CMRPG8J0661"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The deleterious effect of maternal high-fat diet (HFD) on the fetal rat liver may cause later development of non-alcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the effect of maternal HFD-induced maternal hepatic steatosis and dysbiosis on the fetal liver and intestines, and the effect of prenatal metformin in a rat model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sprague\u2013Dawley rats were assigned to three groups (<jats:italic>N<\/jats:italic>\u2009=\u20096 in each group). Before mating, the rats were randomly assigned to HFD or normal-chow diet (NCD) group for 7 weeks. After mating, the HFD group rats were continued with high-fat diet during pregnancy and some of the HFD group rats were co-treated with metformin (HFMf) via drinking water during pregnancy. All maternal rats and their fetuses were sacrificed on gestational day 21. The liver and intestinal tissues of both maternal and fetal rats were analyzed. In addition, microbial deoxyribonucleic acid extracted from the maternal fecal samples was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HFD resulted in maternal weight gain during pregnancy, intrahepatic lipid accumulation, and change in the serum short-chain fatty acid profile, intestinal tight junctions, and dysbiosis in maternal rats. The effect of HFD on maternal rats was alleviated by prenatal metformin, which also ameliorated inflammation and apoptosis in the fetal liver and intestines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrated the beneficial effects of prenatal metformin on maternal liver steatosis, focusing on the gut-liver axis. In addition, the present study indicates that prenatal metformin could ameliorate maternal HFD-induced inflammation and apoptosis in the fetal liver and intestines. This beneficial effect of in-utero exposure of metformin on fetal liver and intestines has not been reported. This study supports the use of prenatal metformin for pregnant obese women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-021-01521-w","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T10:02:50Z","timestamp":1631095370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Szu-Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Che","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Shu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Tung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Lin","family":"Tain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Ming","family":"Sheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chou","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Meng","family":"Tiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S2213-8587(16)30217-0","volume":"4","author":"L Poston","year":"2016","unstructured":"Poston L, Caleyachetty R, Cnattingius S, Corval\u00e1n C, Uauy R, Herring S, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endo. 2016;4:1025\u201336.","journal-title":"Lancet Diabetes Endo"},{"key":"1521_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2016.01.004","volume":"47","author":"E Zambrano","year":"2016","unstructured":"Zambrano E, Ibanez C, Martinez-Samayoa PM, Lomas-Soria C, Durand-Carbajal M, Rodriguez-Gonzalez GL. Maternal obesity: lifelong metabolic outcomes for offspring from poor developmental trajectories during the perinatal period. Arch Med Res. 2016;47:1\u201312.","journal-title":"Arch Med Res"},{"key":"1521_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5784","author":"S Kislal","year":"2020","unstructured":"Kislal S, Shook LL, Edlow AG. Perinatal exposure to maternal obesity: Lasting cardiometabolic impact on offspring. Prenat Diagn. 2020. https:\/\/doi.org\/10.1002\/pd.5784.","journal-title":"Prenat Diagn"},{"key":"1521_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","volume":"86","author":"C Gilbert","year":"2006","unstructured":"Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril. 2006;86:658\u201363.","journal-title":"Fertil Steril"},{"key":"1521_CR5","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","volume":"137","author":"Obesity in Pregnancy","year":"2021","unstructured":"Obesity in Pregnancy. ACOG Practice Bulletin, Number 230. Obstet Gynecol. 2021;137:e128\u201344.","journal-title":"Obstet Gynecol"},{"key":"1521_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374:434\u201343.","journal-title":"N Engl J Med"},{"key":"1521_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100280","author":"R Nascimento IBd, Fleig","year":"2020","unstructured":"Nascimento IBd, Fleig R, Ribeiro e Silva R, Silva JC. Evaluation on the use of metformin in non-diabetic obese pregnant women: Systematic review and metanalysis. Obesity Med. 2020. https:\/\/doi.org\/10.1016\/j.obmed.2020.100280.","journal-title":"Obesity Med"},{"key":"1521_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","volume":"7","author":"JM Dodd","year":"2019","unstructured":"Dodd JM, Louise J, Deussen AR, Grivell RM, Dekker G, McPhee AJ, et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endo. 2019;7:15\u201324.","journal-title":"Lancet Diabetes Endo"},{"key":"1521_CR9","doi-asserted-by":"publisher","first-page":"136 e131","DOI":"10.1016\/j.ajog.2013.05.001","volume":"209","author":"N Desai","year":"2013","unstructured":"Desai N, Roman A, Rochelson B, Gupta M, Xue X, Chatterjee PK, et al. Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. Am J Obstet Gynecol. 2013;209:136 e131-9.","journal-title":"Am J Obstet Gynecol"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"e115778","DOI":"10.1371\/journal.pone.0115778","volume":"9","author":"H Salomaki","year":"2014","unstructured":"Salomaki H, Heinaniemi M, Vahatalo LH, Ailanen L, Eerola K, Ruohonen ST, et al. Prenatal metformin exposure in a maternal high fat diet mouse model alters the transcriptome and modifies the metabolic responses of the offspring. PLoS One. 2014;9:e115778.","journal-title":"PLoS One"},{"key":"1521_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12986-016-0115-9","volume":"13","author":"K Harris","year":"2016","unstructured":"Harris K, Desai N, Gupta M, Xue X, Chatterjee PK, Rochelson B, et al. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutr Metab (Lond). 2016;13:55.","journal-title":"Nutr Metab (Lond)"},{"key":"1521_CR12","doi-asserted-by":"crossref","unstructured":"Tain YL, Wu KLH, Lee WC, Leu S, Chan JYH. Prenatal metformin therapy attenuates hypertension of developmental origin in male adult offspring exposed to maternal high-fructose and post-weaning high-fat diets. Int J Mol Sci. 2018;19:1066.","DOI":"10.3390\/ijms19041066"},{"key":"1521_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3389\/fphys.2018.01813","volume":"9","author":"D Porras","year":"2018","unstructured":"Porras D, Nistal E, Martinez-Florez S, Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease. Front Physiol. 2018;9:1813.","journal-title":"Front Physiol"},{"key":"1521_CR14","doi-asserted-by":"crossref","unstructured":"Gomez-Zorita S, Aguirre L, Milton-Laskibar I, Fernandez-Quintela A, Trepiana J, Kajarabille N, et al. Relationship between changes in microbiota and liver steatosis induced by high-fat feeding-a review of rodent models. Nutrients 2019;11:2156.","DOI":"10.3390\/nu11092156"},{"key":"1521_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12944-018-0824-3","volume":"17","author":"MM Tiao","year":"2018","unstructured":"Tiao MM, Lin YJ, Yu HR, Sheen JM, Lin IC, Lai YJ, et al. Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system. Lipids Health Dis. 2018;17:178.","journal-title":"Lipids Health Dis"},{"key":"1521_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.trsl.2014.07.005","volume":"164","author":"CM Tsai","year":"2014","unstructured":"Tsai CM, Kuo HC, Hsu CN, Huang LT, Tain YL. Metformin reduces asymmetric dimethylarginine and prevents hypertension in spontaneously hypertensive rats. Transl Res. 2014;164:452\u20139.","journal-title":"Transl Res"},{"key":"1521_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/ijms17030369","volume":"17","author":"YH Huang","year":"2016","unstructured":"Huang YH, Chen CJ, Tang KS, Sheen JM, Tiao MM, Tain YL, et al. Postnatal high-fat diet increases liver steatosis and apoptosis threatened by prenatal dexamethasone through the oxidative effect. Int J Mol Sci. 2016;17:369.","journal-title":"Int J Mol Sci"},{"key":"1521_CR18","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9:e96801.","journal-title":"PLoS One"},{"key":"1521_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1083\/jcb.103.3.755","volume":"103","author":"BR Stevenson","year":"1986","unstructured":"Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (Zonula Occludens) in a variety of epithelia. J Cell Biol. 1986;103:755\u201366.","journal-title":"J Cell Biol"},{"key":"1521_CR20","doi-asserted-by":"crossref","unstructured":"Bidlack WR. Nutritional Biochemistry, Tom Brody. San Diego; 1999. (2000) p. 419-420.","DOI":"10.1080\/07315724.2000.10718940"},{"key":"1521_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11:577\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"1521_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0888-7543(88)90003-1","volume":"2","author":"AC Ferguson-Smith","year":"1988","unstructured":"Ferguson-Smith AC, Chen YF, Newman MS, May LT, Sehgal PB, Ruddle FH. Regional localization of the interferon- \u03b22 B-cell stimulatory factor 2\/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics. 1988;2:203\u20138.","journal-title":"Genomics"},{"key":"1521_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3389\/fendo.2019.00665","volume":"10","author":"M Jiang","year":"2019","unstructured":"Jiang M, Li C, Liu Q, Wang A, Lei M. Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2019;10:665.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1521_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jss.2004.04.016","volume":"121","author":"N Harada","year":"2004","unstructured":"Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N, et al. Akt activation protects rat liver from ischemia\/reperfusion injury. J Surg Res. 2004;121:159\u201370.","journal-title":"J Surg Res"},{"key":"1521_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/dom.13592","volume":"21","author":"CJ Green","year":"2019","unstructured":"Green CJ, Marjot T, Tomlinson JW, Hodson L. Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis? Diabetes Obes Metab. 2019;21:749\u201360.","journal-title":"Diabetes Obes Metab"},{"key":"1521_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/ijmm.2013.1560","volume":"33","author":"F Liu","year":"2014","unstructured":"Liu F, Wang C, Zhang L, Xu Y, Jang L, Gu Y, et al. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein. Int J Mol Med. 2014;33:51\u20138.","journal-title":"Int J Mol Med"},{"key":"1521_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4161\/15548627.2014.984271","volume":"11","author":"YM Song","year":"2015","unstructured":"Song YM, Lee YH, Kim JW, Ham DS, Kang ES, Cha BS, et al. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Autophagy. 2015;11:46\u201359.","journal-title":"Autophagy"},{"key":"1521_CR28","doi-asserted-by":"crossref","unstructured":"Conde de la Rosa L, Vrenken TE, Buist-Homan M, Faber KN, Moshage H. Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol Res Perspect. 2015;3:e00125.","DOI":"10.1002\/prp2.125"},{"key":"1521_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.phrs.2019.01.026","volume":"141","author":"W Dornas","year":"2019","unstructured":"Dornas W, Lagente V. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. Pharmacol Res. 2019;141:418\u201328.","journal-title":"Pharmacol Res"},{"key":"1521_CR30","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1128\/AEM.01357-14","volume":"80","author":"H Lee","year":"2014","unstructured":"Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol. 2014;80:5935\u201343.","journal-title":"Appl Environ Microbiol"},{"key":"1521_CR31","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.1038\/s41598-017-11744-6","volume":"7","author":"I Pierantonelli","year":"2017","unstructured":"Pierantonelli I, Rychlicki C, Agostinelli L, Giordano DM, Gaggini M, Fraumene C, et al. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Sci Rep. 2017;7:12200.","journal-title":"Sci Rep"},{"key":"1521_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/EJE-18-0826","volume":"180","author":"HS Ejtahed","year":"2019","unstructured":"Ejtahed HS, Tito RY, Siadat SD, Hasani-Ranjbar S, Hoseini-Tavassol Z, Rymenans L, et al. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur J Endocrinol. 2019;180:165\u201376.","journal-title":"Eur J Endocrinol"},{"key":"1521_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jn\/nxx027","volume":"148","author":"S Lee","year":"2018","unstructured":"Lee S, Keirsey KI, Kirkland R, Grunewald ZI, Fischer JG, de La Serre CB. Blueberry Supplementation Influences the Gut Microbiota, Inflammation, and Insulin Resistance in High-Fat-Diet-Fed Rats. J Nutr. 2018;148:209\u201319.","journal-title":"J Nutr"},{"key":"1521_CR34","first-page":"1133","volume":"21","author":"Y Xie","year":"2020","unstructured":"Xie Y, Ding F, Di W, Lv Y, Xia F, Sheng Y, et al. Impact of a highfat diet on intestinal stem cells and epithelial barrier function in middleaged female mice. Mol Med Rep. 2020;21:1133\u201344.","journal-title":"Mol Med Rep"},{"key":"1521_CR35","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.1038\/s41598-017-04989-8","volume":"7","author":"R Ahmad","year":"2017","unstructured":"Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB. Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching. Sci Rep. 2017;7:5125.","journal-title":"Sci Rep"},{"key":"1521_CR36","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1038\/s41598-019-43228-0","volume":"9","author":"A Brandt","year":"2019","unstructured":"Brandt A, Hernandez-Arriaga A, Kehm R, Sanchez V, Jin CJ, Nier A, et al. Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci Rep. 2019;9:6668.","journal-title":"Sci Rep"},{"key":"1521_CR37","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.1021\/acs.jafc.8b02979","volume":"66","author":"W Li","year":"2018","unstructured":"Li W, Zhang K, Yang H. Pectin alleviates high fat (lard) diet-induced nonalcoholic fatty liver disease in mice: possible role of short-chain fatty acids and gut microbiota regulated by pectin. J Agric Food Chem. 2018;66:8015\u201325.","journal-title":"J Agric Food Chem"},{"key":"1521_CR38","doi-asserted-by":"publisher","first-page":"31263","DOI":"10.1074\/jbc.M111.238147","volume":"286","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Yoshinaga N, Tanabe S. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem. 2011;286:31263\u201371.","journal-title":"J Biol Chem"},{"key":"1521_CR39","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","volume":"103","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1521_CR40","doi-asserted-by":"publisher","first-page":"e17261","DOI":"10.1371\/journal.pone.0017261","volume":"6","author":"WF Grant","year":"2011","unstructured":"Grant WF, Gillingham MB, Batra AK, Fewkes NM, Comstock SM, Takahashi D, et al. Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One. 2011;6:e17261.","journal-title":"PLoS One"},{"key":"1521_CR41","doi-asserted-by":"publisher","first-page":"4234061","DOI":"10.1155\/2016\/4234061","volume":"2016","author":"S Li","year":"2016","unstructured":"Li S, Hong M, Tan HY, Wang N, Feng Y. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases. Oxid Med Cell Longev. 2016;2016:4234061.","journal-title":"Oxid Med Cell Longev"},{"key":"1521_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","volume":"53","author":"J Xiao","year":"2014","unstructured":"Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TY, et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways. Eur J Nutr. 2014;53:187\u201399.","journal-title":"Eur J Nutr"},{"key":"1521_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11684-015-0384-0","volume":"9","author":"J Zheng","year":"2015","unstructured":"Zheng J, Woo SL, Hu X, Botchlett R, Chen L, Huo Y, et al. Metformin and metabolic diseases: a focus on hepatic aspects. Front Med. 2015;9:173\u201386.","journal-title":"Front Med"},{"key":"1521_CR44","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/jdi.12328","volume":"6","author":"KY Hur","year":"2015","unstructured":"Hur KY, Lee MS. New mechanisms of metformin action: Focusing on mitochondria and the gut. J Diabetes Investig. 2015;6:600\u20139.","journal-title":"J Diabetes Investig"},{"key":"1521_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.29347","volume":"67","author":"OT Ayonrinde","year":"2018","unstructured":"Ayonrinde OT, Adams LA, Mori TA, Beilin LJ, de Klerk N, Pennell CE, et al. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents. Hepatology. 2018;67:108\u201322.","journal-title":"Hepatology"},{"key":"1521_CR46","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/humupd\/dmu037","volume":"20","author":"VN Sivalingam","year":"2014","unstructured":"Sivalingam VN, Myers J, Nicholas S, Balen AH, Crosbie EJ. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update. 2014;20:853\u201368.","journal-title":"Hum Reprod Update"},{"key":"1521_CR47","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00125-017-4351-y","volume":"60","author":"RS Lindsay","year":"2017","unstructured":"Lindsay RS, Loeken MR. Metformin use in pregnancy: promises and uncertainties. Diabetologia. 2017;60:1612\u20139.","journal-title":"Diabetologia"},{"key":"1521_CR48","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/s41598-018-23965-4","volume":"8","author":"BE Gregg","year":"2018","unstructured":"Gregg BE, Botezatu N, Brill JD, Hafner H, Vadrevu S, Satin LS, Alejandro EU, Bernal-Mizrachi E. Gestational exposure to metformin programs improved glucose tolerance and insulin secretion in adult male mouse offspring. Sci Rep. 2018;8:5745.","journal-title":"Sci Rep"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-021-01521-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01521-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T08:07:48Z","timestamp":1675670868000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01521-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01521-w","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Institutional Animal Care and Use Committee of the Kaohsiung Chang Gung Memorial Hospital (Approval No. 2019052802; Valid period:20191001\u2009~\u200920210930).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}